These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12627926)

  • 1. Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.
    Caron MF; Kluger J; Tsikouris JP; Ritvo A; Kalus JS; White CM
    Pharmacotherapy; 2003 Mar; 23(3):296-300. PubMed ID: 12627926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
    Tercius AJ; Kluger J; Coleman CI; White CM
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1331-5. PubMed ID: 17976094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
    Steinwender C; Hönig S; Kypta A; Kammler J; Schmitt B; Leisch F; Hofmann R
    Int J Cardiol; 2010 Jun; 141(3):260-5. PubMed ID: 19136164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
    Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
    Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
    Gowda RM; Punukollu G; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2003; 10(4):259-63. PubMed ID: 12845389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.
    Kalus JS; Spencer AP; Tsikouris JP; Chung JO; Kenyon KW; Ziska M; Kluger J; White CM
    Am J Health Syst Pharm; 2003 Nov; 60(22):2308-12. PubMed ID: 14652979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
    Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
    Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
    Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
    J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
    Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter.
    Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A
    Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical cardioversion of atrial flutter and fibrillation in the pediatric population with Ibutilide.
    Dasgupta S; Dave I; Whitehill R; Fischbach P
    Pacing Clin Electrophysiol; 2020 Mar; 43(3):322-326. PubMed ID: 32086826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
    Coleman CI; Sood N; Chawla D; Talati R; Ghatak A; Kluger J;
    Europace; 2009 Jul; 11(7):892-5. PubMed ID: 19351630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
    Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
    Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?
    Varriale P; Sedighi A
    Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.